After our last episode on GLP-1 drugs, benefits industry veteran Barbara Flitsch reached out with a different take—one shaped by both her personal experience as a GLP-1 recipient and her 35+ years in the field. She joins Vlad for a candid discussion on how these medications are changing lives, why holistic care is key to success, and what employers need to consider in the evolving benefits landscape.
Learn more about Airbo atwww.airbo.com
